{"id":"https://openalex.org/W4290350433","doi":null,"title":"Long-term anxiolytic therapy: the issue of drug withdrawal.","display_name":"Long-term anxiolytic therapy: the issue of drug withdrawal.","publication_year":1987,"publication_date":"1987-12-01","ids":{"openalex":"https://openalex.org/W4290350433","pmid":"https://pubmed.ncbi.nlm.nih.gov/2891684"},"language":"en","primary_location":{"id":"pmid:2891684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2891684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108285762","display_name":"MALCOLM H. LADER","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"M Lader","raw_affiliation_strings":["Department of Clinical Psychopharmacology, University of London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Psychopharmacology, University of London, England","institution_ids":["https://openalex.org/I124357947"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5108285762"],"corresponding_institution_ids":["https://openalex.org/I124357947"],"apc_list":null,"apc_paid":null,"fwci":2.1483,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.8883194,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"48 Suppl","issue":null,"first_page":"12","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0284000001847744,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal","display_name":"benzodiazepine withdrawal","score":0.9520000219345093},{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":0.8930000066757202},{"id":"https://openalex.org/keywords/benzodiazepine-dependence","display_name":"benzodiazepine dependence","score":0.9229999780654907},{"id":"https://openalex.org/keywords/drug-abuse-liability","display_name":"drug abuse liability","score":0.6290000081062317},{"id":"https://openalex.org/keywords/cross-tolerance","display_name":"cross-tolerance","score":0.8230000138282776},{"id":"https://openalex.org/keywords/barbiturates","display_name":"barbiturates","score":0.9739999771118164},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.5210000276565552},{"id":"https://openalex.org/keywords/withdrawal-symptoms","display_name":"withdrawal symptoms","score":0.460999995470047},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5460000038146973}],"concepts":[{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.9350835680961609},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.7550370693206787},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.7522518634796143},{"id":"https://openalex.org/C2778195246","wikidata":"https://www.wikidata.org/wiki/Q2622112","display_name":"Physical dependence","level":3,"score":0.659407913684845},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6060584187507629},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5801841020584106},{"id":"https://openalex.org/C2780077838","wikidata":"https://www.wikidata.org/wiki/Q206348","display_name":"Barbiturate","level":2,"score":0.5677006840705872},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5177830457687378},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4344680905342102},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42869114875793457},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.27546900510787964},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14100590348243713},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.12206929922103882},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.08521497249603271},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07279998064041138}],"mesh":[{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:2891684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2891684","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2063980879","https://openalex.org/W1972791990","https://openalex.org/W2915292947","https://openalex.org/W69979210","https://openalex.org/W1970085072","https://openalex.org/W2011333907","https://openalex.org/W5861412","https://openalex.org/W2091919635","https://openalex.org/W2018087603","https://openalex.org/W2004185004"],"abstract_inverted_index":{"Although":[0,69,178],"widespread":[1],"use":[2,85],"has":[3,81],"confirmed":[4],"their":[5,31,84],"efficacy":[6],"as":[7,22,27,122,127,204],"anxiolytic":[8,78,190],"agents,":[9,52,79],"the":[10,74,103,128,158,162],"benzodiazepine":[11,41,70,129,163],"drugs":[12,42,71,130,164],"are":[13,99],"indicated":[14],"only":[15],"for":[16,33,186,194],"short-term":[17],"or":[18,36,48,101,145,161],"intermittent":[19],"therapy":[20,88],"at":[21,171],"low":[23,97],"a":[24,169,176],"therapeutic":[25],"dose":[26],"possible":[28],"because":[29],"of":[30],"liability":[32],"causing":[34,54,132],"dependence":[35,65,144],"abuse.":[37],"When":[38],"first":[39],"introduced,":[40],"appeared":[43],"to":[44,50,120,141,167,181,208],"be":[45,121,168,182],"therapeutically":[46],"equal":[47],"superior":[49],"barbiturate":[51,159],"while":[53,131],"fewer":[55,64,133],"side":[56,200],"effects,":[57],"being":[58],"safer":[59],"in":[60,86,124],"overdose,":[61],"and":[62,66,115,165,197],"producing":[63],"abuse":[67,146],"problems.":[68,135],"have":[72],"become":[73],"most":[75],"commonly":[76],"prescribed":[77],"evidence":[80],"emerged":[82],"that":[83],"long-term":[87],"can":[89],"cause":[90,142],"severe":[91],"withdrawal":[92,134,195],"problems,":[93],"even":[94],"when":[95,102],"relatively":[96],"doses":[98,173],"used":[100],"drug":[104,152,185],"is":[105,202,206],"discontinued":[106],"gradually.":[107],"Based":[108],"on":[109],"results":[110],"from":[111],"both":[112],"animal":[113],"models":[114],"clinical":[116],"investigations,":[117],"buspirone":[118,149,179,205],"appears":[119],"effective":[123],"treating":[125],"anxiety":[126],"Data":[136],"suggest":[137],"no":[138,154],"appreciable":[139],"propensity":[140],"physical":[143],"associated":[147],"with":[148,156],"therapy.":[150],"The":[151],"demonstrates":[153],"cross-tolerance":[155],"either":[157],"agents":[160],"seems":[166,180],"dysphoriant":[170],"high":[172],"rather":[174],"than":[175],"euphoriant.":[177],"an":[183],"appropriate":[184],"patients":[187],"requiring":[188],"longer-term":[189],"therapy,":[191],"careful":[192],"monitoring":[193],"problems":[196],"other":[198],"adverse":[199],"effects":[201],"essential":[203],"introduced":[207],"successive":[209],"markets.":[210]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-08-07T00:00:00"}